Multiomics Market
Multiomics Market Size, Share & Trends Analysis Report by Product & Services (Product and Services), by Type (Single-cell Multiomics and Bulk Multiomics), by Application (Cell Biology, Oncology, Neurology, and Immunology), by End-User (Pharma & Biotech Companies, Academics & Research Organization, and Hospital & Diagnostic Laboratories), Forecast Period (2024-2031)
Multiomics market is anticipated to grow at a considerable CAGR of 16.5% during the forecast period (2024-2031). Advancements in multiomics technology along with its growing application in the treatment of several disorders is a key factor driving the growth of the global market. The discovery of new application areas of multiomics is further aiding the market growth. In March 2023, the researchers generated a spatially resolved multiomics single-cell atlas of the entire human-maternal–fetal interface including the myometrium, which enables them to resolve the full trajectory of trophoblast differentiation during the first trimester of pregnancy.
The growing interest of researchers in single-cell genomics is further contributing to the market growth. As per the research published by the National Library of Medicine in March 2023, single-cell genomics is found to have numerous applications in the field of cardiovascular disorder research. It can be utilized in heart development, Myocardial Infarction, Cardiac reperfusion injury, atherosclerosis, atrial fibrillation, cardiac hypertrophy, and heart failure.
Looking towards the potential of this market, new startups are entering into this field with funding from venture capitalists. In December 2023, Pepper Bio developer of the COMPASS platform announced an oversubscribed $6.5 million seed round with participation from NFX, Merck Digital Sciences Studio, Mana Ventures, Silverton Partners, Tensility Ventures, VSC Ventures, and others. This funding will accelerate Pepper Bio’s transomics platform capabilities, fueling the pipeline.
Segmental Outlook
The global multiomics market is segmented based on product & services, type, application, and end-user. Based on products & services, the market is segmented into products & services. Product is further sub-segmented into instruments, consumables, and software. Based on type, the market is segmented into single-cell multiomics and bulk multiomics. Based on application, the market is segmented into cell biology, oncology, neurology, and immunology. Based on end-user, the market is segmented into
Service Segment is Anticipated to Exhibit Considerable CAGR in the Global Multiomics Market
The growing demand for numerous multiomics services has promoted market players to launch several services in the market. New product launches are a key factor driving the growth of this market segment. In September 2023, Multiomics CRO Psomagen launched Spatial Biology services for 10X Genomics Xenium. This platform is reshaping spatial biology, enabling researchers worldwide to analyze the interplay of genes and proteins within their native tissue context. This marks a pivotal moment in the scientific community's access to spatial genomics. Further, in April 2021, Mission Bio launched its Pharma Assay Development (PAD) service, enabling its customers to obtain early access services based on the newest technologies as well as on its existing products. This will support users to implement single-cell multiomics capabilities in their drug discovery, translation, and clinical research endeavors in oncology.
Regional Outlook
The global multiomics market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit considerable growth in the global market. The growing interest of regional pharmaceutical companies in the R&D of genomics is a key factor driving the regional market growth.
Global Multiomics Market Growth, by Region 2024-2031
North America Held Considerable Share in the Global Market
The regional market share is driven by the high R&D activities across the region in the fields of genomics, transcriptomics, proteomics, and metabolomics owing to the presence of several key market players. Additionally, increasing investment and government initiatives in this field are also contributing to the high share of the regional market. For instance, in November 2023, The Texas A&M University System received a $1.19 million grant from the National Institutes of Health (NIH) for a multidisciplinary collaboration to study the intricate connections between genomics, nutrition, and health. Understanding these connections will help in the diagnosis and treatment of cancer and other diseases.
Market Players Outlook
The major companies serving the global multiomics market include Bio Rad Laboratories, Inc., Thermo Fischer Scientific Inc., Mission Bio, Inc., Danaher Corp., and Illumina among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and advancement in their software offerings to stay competitive in the market. For instance, in April 2023, Bio-Techne entered a strategic partnership with Lunaphore for the development of a fully automated spatial multiomics solution. Under the partnership, the companies will engage in the development of the first fully automated spatial multiomics workflow for same-slide hyperplex detection of protein and RNA biomarkers. The new solution is expected to offer ultimate flexibility in panel design. It will support researchers to easily incorporate antibodies with RNAscope in situ hybridization probes to highlight changes in cell phenotypes and functional states across different diseases.
The Report Covers
- Market value data analysis of 2023 and forecast to 2031.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global multiomics market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.2. Bio Rad Laboratories, Inc.
3.2.1. Overview
3.2.2. Financial Analysis
3.2.3. SWOT Analysis
3.2.4. Recent Developments
3.3. Thermo Fisher Scientific, Inc.
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
3.4. Mission Bio, Inc.
3.4.1. Overview
3.4.2. Financial Analysis
3.4.3. SWOT Analysis
3.4.4. Recent Developments
3.5. Key Strategy Analysis
4. Market Segmentation
4.1. Global Multiomics Market by Products & Services
4.1.1. Products
4.1.1.1. Instruments
4.1.1.2. Consumables
4.1.1.3. Software
4.1.2. Services
4.2. Global Multiomics Market by Type
4.2.1. Single-Cell Multiomics
4.2.2. Bulk Multiomics
4.3. Global Multiomics Market by Application
4.3.1. Cell Biology
4.3.2. Oncology
4.3.3. Neurology
4.3.4. Immunology
4.4. Global Multiomics Market by End-User
4.4.1. Pharma & Biotech Companies
4.4.2. Academics & Research Organization
4.4.3. Hospital and Diagnostic Laboratories
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. 10x Genomics, Inc.
6.2. Becton, Dickinson and Company
6.3. Berkeley Lights Inc
6.4. BGI Genomics Co. Ltd
6.5. Danaher Corp (Cytiva Life Sciences)
6.6. Dolomite Bio
6.7. Epicypher Inc.
6.8. Fluidigm Corp
6.9. Illumina, Inc
6.10. Miltenyi Biotec B.V. & CO.
6.11. Nanostring Technologies, Inc
6.12. Olink Holding AB (Olink Proteomics)
6.13. Parse Bioscience
6.14. Qiagen N.V.
6.15. Takara Holdings Inc. Takara Bio Group
1. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023-2031 ($ MILLION)
2. GLOBAL MULTIOMICS PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
3. GLOBAL MULTIOMICS SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
4. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
5. GLOBAL SINGLE-CELL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
6. GLOBAL BULK MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
7. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
8. GLOBAL MULTIOMICS FOR CELL BIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
9. GLOBAL MULTIOMICS FOR ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
10. GLOBAL MULTIOMICS FOR IMMUNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
11. GLOBAL MULTIOMICS FOR NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
12. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
13. GLOBAL MULTIOMICS FOR PHARMA & BIOTECH COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
14. GLOBAL MULTIOMICS FOR ACADEMICS & RESEARCH ORGANIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
15. GLOBAL MULTIOMICS FOR HOSPITAL AND DIAGNOSTIC LABORATORIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
16. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
17. NORTH AMERICAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
18. NORTH AMERICAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023-2031 ($ MILLION)
19. NORTH AMERICAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
20. NORTH AMERICAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
21. NORTH AMERICAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
22. EUROPEAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
23. EUROPEAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023-2031 ($ MILLION)
24. EUROPEAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
25. EUROPEAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
26. EUROPEAN MULTIOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
27. ASIA-PACIFIC MULTIOMICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2023-2031 ($ MILLION)
28. ASIA-PACIFIC MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023-2031 ($ MILLION)
29. ASIA-PACIFIC MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
30. ASIA-PACIFIC MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
31. ASIA-PACIFIC MULTIOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
32. REST OF THE WORLD MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023-2031 ($ MILLION)
33. REST OF THE WORLD MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023-2031 ($ MILLION)
34. REST OF THE WORLD MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023-2031 ($ MILLION)
35. REST OF THE WORLD MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023-2031 ($ MILLION)
36. REST OF THE WORLD TEST MARKET RESEARCH AND ANALYSIS BY END-USER, 2023-2031 ($ MILLION)
1. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY PRODUCTS & SERVICES, 2023 VS 2031 (%)
2. GLOBAL MULTIOMICS PRODUCTS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
3. GLOBAL MULTIOMICS SERVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
4. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY TYPE, 2023 VS 2031 (%)
5. GLOBAL SINGLE-CELL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
6. GLOBAL BULK MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
7. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2023 VS 2031 (%)
8. GLOBAL MULTIOMICS FOR CELL BIOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
9. GLOBAL MULTIOMICS FOR ONCOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
10. GLOBAL MULTIOMICS FOR NEUROLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
11. GLOBAL MULTIOMICS FOR IMMUNOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
12. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2023 VS 2031 (%)
13. GLOBAL MULTIOMICS FOR PHARMA & BIOTECH COMPANIES MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
14. GLOBAL MULTIOMICS FOR ACADEMICS & RESEARCH ORGANIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
15. GLOBAL MULTIOMICS MARKET RESEARCH AND ANALYSIS BY REGION, 2023 VS 2031 (%)
16. US MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
17. CANADA MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
18. UK MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
19. FRANCE MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
20. GERMANY MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
21. ITALY MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
22. SPAIN MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
23. REST OF EUROPE MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
24. INDIA MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
25. CHINA MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
26. JAPAN MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
27. SOUTH KOREA MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
28. REST OF ASIA-PACIFIC MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
29. REST OF THEWORLD MULTIOMICS MARKET SIZE, 2023-2031 ($ MILLION)
